| Financial Year |
March 31 2023 |
| Monetary Funds |
1,702,845,906.65 |
| Held-for-trading Financial Assets |
657,769,742.07 |
| Notes Receivable |
33,300,000.00 |
| Accounts Receivable |
391,341,240.11 |
| Advances to Suppliers |
69,134,674.38 |
| Other Receivables |
29,730,430.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
849,390,106.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,266,791,205.09 |
| Other Current Assets |
308,552,700.73 |
| Total Current Assets |
5,308,856,005.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
551,450,276.22 |
| Investment Properties |
316,331,763.72 |
| Fixed Assetes |
386,838,435.47 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
354,033,836.81 |
| R&D expenses |
2,760,467.52 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
158,756,328.53 |
| Deferred Income Tax Assets |
271,309,412.26 |
| Other Non-Current Assets |
3,019,548,390.42 |
| Sub-Total of Non-Current Assets |
5,660,091,429.25 |
| Total Assets |
10,968,947,435.24 |
| Short-Term Loans |
2,347,070,139.64 |
| Trading Financial liabilities |
-- |
| Notes Payable |
726,149,385.82 |
| Accounts Payable |
431,136,404.34 |
| Accounts Received In Advance |
3,881,330.39 |
| Employee Compensation Payable |
41,250,839.76 |
| Taxes Payable |
90,699,073.16 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
232,411,475.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
73,263,030.94 |
| Other Current Liabilities |
188,560,050.26 |
| Sub-Total of Current Liabilities |
4,438,994,611.64 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,403,604.00 |
| Deferred Income Tax Liabilities |
69,312,917.77 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
139,707,452.66 |
| Total Liabilities |
4,578,702,064.30 |
| Paid-In Capital(Or Share Stock) |
755,670,000.00 |
| Capital Surplus |
1,880,097,031.53 |
| Surplus Reserve |
857,554,484.32 |
| LESS:Treasury Stock |
290,860,284.26 |
| Undistributed Profits |
3,050,836,707.05 |
| Minority Stockholder's Interest |
118,439,264.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,271,806,106.03 |
| Owner's Equity（Stockholder's Equity） |
6,390,245,370.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,968,947,435.24 |
